Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
443
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
-6.56M
-
Total reported value, excl. options
-
$7.6B
-
Value change
-
-$458M
-
Put/Call ratio
-
0.26
-
Number of buys
-
191
-
Number of sells
-
-226
-
Price
-
$71.54
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2024
506 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2024.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 443 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
of 115M outstanding shares and own 92.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.6M shares), BlackRock, Inc. (10.3M shares), JANUS HENDERSON GROUP PLC (7M shares), STATE STREET CORP (3.57M shares), JPMORGAN CHASE & CO (2.6M shares), WELLINGTON MANAGEMENT GROUP LLP (2.58M shares), Burgundy Asset Management Ltd. (2.57M shares), Bank of New York Mellon Corp (2.36M shares), Sculptor Capital LP (2.21M shares), and HAWK RIDGE CAPITAL MANAGEMENT LP (2.18M shares).
This table shows the top 443 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.